Latest glioblastoma multiforme Stories
NovoTTF™-100A System Offers Novel, Non-Invasive Treatment in Fight Against an Aggressive Type of Brain Cancer Morristown,NJ (PRWEB) August 27, 2014
DelMar Is Advancing Clinical Trials With VAL-083 As A New Chemotherapy For Refractory Glioblastoma Multiforme VANCOUVER, British Columbia and MENLO PARK, Calif., Aug.
Researchmoz.us added deep and professional market research reports on "Global and China Power Battery Management System (BMS) Industry Report, 2014-2017" Market Analysis and Overview.
MarketResearchReports.Biz include new market research report "Glioblastoma Multiforme Therapeutics In Asia-Pacific Markets To 2020 - Novel Therapeutic Approaches Target High Unmet Need In
Japanese Society of Neuro-Oncology calls for rapid approval by the Japanese Ministry of Health and Welfare (MHLW) ST. HELIER, Jersey, Aug.
Funding To Increase Manufacturing Capacity for Ramp-Up of Programs BETHESDA, Md., Aug.
VAL-083 Phase I/II VAL-083 clinical trial advances to 50mg/m(2) cohort VANCOUVER, British Columbia and MENLO PARK, Calif., Aug.
A smart technology which involves smuggling gold nanoparticle into brain cancer cells has proven highly effective in lab-based tests
CEO to Present Significance of Announced Clinical Trial Results for Lead Drug G-202 Treating Hepatocellular Carcinoma (HCC) Patients to Wall Street Audience SAN ANTONIO, Aug.
Phase III Trial Is Alive And Well; "Hint Of Failure" A Complete Fabrication; No Interim Analysis of Efficacy Done; 55 Patients' Positive Data Independently Collected. BETHESDA, Md., Aug.